在药物流行病学研究中使用处方药索赔数据来识别降脂药物暴露：潜在陷阱。 - Suppr | 超能文献

Use of prescription drug claims data to identify lipid-lowering medication exposure in pharmacoepidemiology studies: potential pitfalls.

作者信息

Brunelli Steven M

机构信息

DaVita Clinical Research, Minneapolis, MN, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):844-6. doi: 10.1002/pds.4017. Epub 2016 May 4.

DOI:10.1002/pds.4017

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Use of prescription drug claims data to identify lipid-lowering medication exposure in pharmacoepidemiology studies: potential pitfalls.在药物流行病学研究中使用处方药索赔数据来识别降脂药物暴露：潜在陷阱。

Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):844-6. doi: 10.1002/pds.4017. Epub 2016 May 4.

2

Changes in nationwide Medicare and Medicaid expenditures on lipid-lowering therapies after proprotein convertase/subtilisin type 9 inhibitor availability.载脂蛋白转化酶枯草溶菌素 9 抑制剂上市后降脂治疗药物在医疗保险和医疗补助方面的全国性支出变化。

J Clin Lipidol. 2020 May-Jun;14(3):315-321.e4. doi: 10.1016/j.jacl.2020.04.003. Epub 2020 Apr 13.

3

Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.医疗保险部分 D 覆盖缺口对高血压和高血脂患者用药的影响。

Ann Intern Med. 2012 Jun 5;156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. doi: 10.7326/0003-4819-156-11-201206050-00004.

4

Agreement between Medicare pharmacy claims, self-report, and medication inventory for assessing lipid-lowering medication use.医疗保险药房报销记录、自我报告与药物库存之间关于评估降脂药物使用情况的一致性。

Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):827-35. doi: 10.1002/pds.3970. Epub 2016 Jan 29.

5

Economic grand rounds: did Medicare Part D improve access to medications?经济大查房：医疗保险药品计划是否改善了药物的可及性？

Psychiatr Serv. 2010 Feb;61(2):118-20. doi: 10.1176/ps.2010.61.2.118.

6

Use of prescription drug samples in the US and implications for pharmacoepidemiologic research: a systematic search of the literature.美国处方药样本的使用及其对药物流行病学研究的影响：系统文献检索。

Expert Rev Pharmacoecon Outcomes Res. 2021 Aug;21(4):541-551. doi: 10.1080/14737167.2021.1905528. Epub 2021 Apr 29.

7

Impact of cost sharing on prescription drugs used by Medicare beneficiaries.医疗保险受益人的处方药费用分担的影响。

Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.

8

Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.医疗保险D部分实施前后青光眼弱势受益人群中处方药覆盖范围参保情况的变化

JAMA Ophthalmol. 2016 Feb;134(2):212-20. doi: 10.1001/jamaophthalmol.2015.5090.

9

Impact of provider mailings on medication adherence by Medicare Part D members.医疗机构邮寄宣传资料对 Medicare Part D 参保人用药依从性的影响。

Healthc (Amst). 2016 Sep;4(3):207-16. doi: 10.1016/j.hjdsi.2016.02.004. Epub 2016 Feb 20.

10

Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.医生收受制药企业回扣款与马萨诸塞州开具品牌名他汀类药物的关联性。

JAMA Intern Med. 2016 Jun 1;176(6):763-8. doi: 10.1001/jamainternmed.2016.1709.

引用本文的文献

1

Comparing Prescribing and Dispensing Data of the PCORnet Common Data Model Within PCORnet Antibiotics and Childhood Growth Study.比较PCORnet抗生素与儿童生长研究中PCORnet通用数据模型的处方和配药数据。

EGEMS (Wash DC). 2019 Apr 12;7(1):11. doi: 10.5334/egems.274.